🇺🇸 FDA
Pipeline program

donor-derived NK cell infusion

PB-2020Allo

Phase 2 mab active

Quick answer

donor-derived NK cell infusion for Non-small Cell Lung Cancer is a Phase 2 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Non-small Cell Lung Cancer
Phase
Phase 2
Modality
mab
Status
active

Clinical trials